Skip to content

Clinical trials

Completed Phase 3 Hypertension trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Phase: Phase 3 Status: Completed Clear all

478 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
200111
200211
200317
200435
200544
200644
200741
200840
200915
201020
201125
201220
201311
201414
20158
20169
20178
20185
20197
20206
20218
20225
20236
20248
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed478

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis78
Boehringer Ingelheim42
National Heart, Lung, and Blood Institute (NHLBI)20
Novartis Pharmaceuticals19
Takeda19
Hanmi Pharmaceutical Company Limited15
AstraZeneca14
Organon and Co13
Alcon Research9
The Medicines Company8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension478
Cardiovascular Diseases49
Essential Hypertension43
Diabetes Mellitus28
Heart Diseases27
Vascular Diseases23
Obesity20
Hyperlipidemias19
Diabetes Mellitus, Type 218
Dyslipidemias17

Trials

Showing 1 to 25 of 478. Each trial links to its page on Pharma Observatory.

378 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.